Leading Researchers Join Biogen Idec To Advance Drug Discovery For Neurodegenerative Diseases

By: via Benzinga
Biogen Idec (NASDAQ: BIIB) today announced that two leading neuroscientists have joined the company to advance its research in ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.